PDGFRB and familial pancreatic carcinoma: A previous report shows that pharmacological PDGFR inhibition sensitizes mouse pancreatic cancer to VEGFR-2-targeting treatment, which could be explained by that PDGFR inhibition eradicates pericytes that protect ECs against pharmacological inhibition of VEGFR-241.